Yersiniosis;YERSINIOSE

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 3, 1996, Pages 128-130

  Hoogkamp Korstanje, J A A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; COTRIMOXAZOLE; HLA B27 ANTIGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

ADULT; AGE; ARTICLE; CHILD; HUMAN; YERSINIA; YERSINIA ENTEROCOLITICA; YERSINIA PESTIS; YERSINIA PSEUDOTUBERCULOSIS; YERSINIOSIS;

ARTHRITIS, INFECTIOUS; ERYTHEMA NODOSUM; HUMANS; YERSINIA ENTEROCOLITICA; YERSINIA INFECTIONS; YERSINIA PSEUDOTUBERCULOSIS INFECTIONS;

EID: 0030030775     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Butler Th, Yersinia infections: centennial of the discovery of the plague bacillus. Clin Infect Dis 1994;19:655-63.
2. Fukushima H. Direct isolation of Yersinia pseudotuberculosis from fresh water in Japan. Appl Environ Microbiol 1992;58:2688-90.
3. Michiels T, Wattiau P, Brasseur R, Ruysschaert JM, Cornelis G. Secretion of Yop proteins by Yersimae. Infect Immun 1990;58:2840-9.
4. Heesemann J, Grùter L. Genetic evidence that outer membrane protein Yopi of Yersinia enterocolitica mediates adherence and phagocytosis resistance to human epithelial cells. FEMS Microbiol Lett 1987;40:37-41.
5. Rosqvist R, Magnusson KE, Wolf-Watz H. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin in mammalian cells. EMBO J 1994;13:964-72.
6. Hartland EL, Green SP, Phillips WA, Robins-Browne RM. Essential role of YopD in inhibition of the respiratory burst of macrophages by Yersinia enterocolitica. Infect Immun 1994;62:4445-53.
7. Hoogkamp-Korstanje JAA, Koning J de, Heesemann J. Persistence of Yersinia enterocolitica in men. Infection 1998;16:81-5.
8. Naumann M, Hanski C, Riecken EO, Expression in vivo of additional plasmid-mediated proteins during intestinal infection with Yersinia enterocolitica serotype 08. J Med Microbiol 1991;35:257-63.
9. Hoogkamp-Korstanje JAA, Koning J de, Heesemann J, Festen JJM. Houtman PM, Oyen PLM van. Influence of antibiotics on IgA and IgG response and persistence of Yersinia enterocolitica in patients with Yersinia-associated spondylarthropathy. Infection 1992;20: 53-7.
10. Koning J de, Heesemann J, Hoogkamp-Korstanje JAA, Festen JJM, Houtman PM, Oyen PLM van. Yersima in intestinal biopsy specimens from patients with seronegative spondylarthropathy: correlation with specific serum IgA antibodies. J Infect Dis 1989;159:109-12.
11. Curfs JHAJ, Meis JFGM, Lee HAL van der, Mulder JA, Kraak WAG, Hoogkamp-Korstanje JAA, Persistent Yersinia enterocolitica in three rat strains. Microbiol Pathol 1995;19:57-63.
12. Toivanen A, Granfors K, Lahesmaa-Rantala R, Leino R, Stahlberg T, Vuento R. Pathogenesis of Yersinia-triggered reactive arthritis: immunological, microbiological and clinical aspects Immunol Rev 1985;86:47-70.
13. Heesemann J, Gaede K, Autenneth IB. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis. APMIS 1993;101:417-29.
14. Hoogkamp-Korstanje JAA, Koning J de, Yersinia enterocoliticainfecties: klinische en histologische kenmerken, diagnostiek en therapie. Ned Tijdschr Geneeskd 1991;135:2218-23.
15. Hoogkamp-Korstanje JAA, Stolk-Engelaar VMM. Yersinia enterocolitica infection in children. Pediatr Infect Dis J 1995 [ter perse].
16. Cover TL, Aber RC. Yersinia enterocolitica. N Engl J Med 1989; 321:16-24
17. Hoogkamp-Korstanje JAA, Koning J de, Samsom JP. Incidence of human infection with Yersinia enterocolitica serotypes 03, 08, and 09 and the use of indirect immunofluorescence in diagnosis. J Infect Dis 1986;153:138-41.
18. Hoogkamp-Korstanje JAA. Antibiotics in Yersinia enterocolitica infections J Antimicrob Chemother 1987;20:123-31.